Novartis AG (NOVN)

Switzerland
Currency in CHF
94.89
-0.32(-0.34%)
Closed·

SIX:NOVN Financials

Key Ratios

P/E Ratio18.1
Price/Book5.63
Debt / Equity81.32%
Return on Equity32.89%
Dividend Yield3.69%
EBITDA20.66B
Fair ValueUnlock
Fair Value UpsideUnlock

Statements Highlights

Period Ending:
2015
31/12
2016
31/12
2017
31/12
2018
31/12
2019
31/12
2020
31/12
2021
31/12
2022
31/12
2023
31/12
2024
31/12
Total Revenues
aa.aaaa.aaaa.aaaa.aaaa.aa49,89843,97443,46146,66051,722
Gross Profit
aa.aaaa.aaaa.aaaa.aaaa.aa34,77732,58331,87934,64038,907
Operating Income
aa.aaaa.aaaa.aaaa.aaaa.aa10,15210,9639,21312,64216,320
Net Income
aa.aaaa.aaaa.aaaa.aaaa.aa8,07224,0216,95514,85011,941
Total Assets
aa.aaaa.aaaa.aaaa.aaaa.aa127,778131,795117,45399,945102,246
Total Current Liabilities
aa.aaaa.aaaa.aaaa.aaaa.aa33,05930,20828,65626,39028,692
Total Equity
aa.aaaa.aaaa.aaaa.aaaa.aa56,66667,82259,42346,75044,126
Levered Free Cash Flow
aa.aaaa.aaaa.aaaa.aaaa.aa11,556.8811,7747,311.1312,132.8812,038.25
Cash from Operations
aa.aaaa.aaaa.aaaa.aaaa.aa13,65015,07114,23614,45817,619
Cash from Investing
aa.aaaa.aaaa.aaaa.aaaa.aa-13,1824,2081,4685,596-7,513
Cash from Financing
aa.aaaa.aaaa.aaaa.aaaa.aa-2,208-16,264-20,562-14,278-11,742
Net Change in Cash
aa.aaaa.aaaa.aaaa.aaaa.aa-1,4542,749-4,8905,876-1,934
* In Millions of USD (except for per share items)

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 6.43%
Dividend Yield
3.69%
Industry Median 1.97%
Annualized Payout
3.50
Paid annually
5-Years Growth
+4.36%
Growth Streak

Analyst Ratings

5 Buy
11 Hold
5 Sell
Ratings:
21 analysts
Overall Consensus
Neutral

Analysts 12-Month Price Target:

Average 97.07
(+2.29% Upside)

Earnings

Latest Release
Apr 29, 2025
EPS / Forecast
2.28 / 2.08
Revenue / Forecast
13.23B / 13.03B
EPS Revisions
Last 90 days

FAQ

What were Novartis's earnings for the latest quarter?

The Novartis EPS (TTM) is 6.43. Novartis reported sales of The Novartis EPS (TTM) is 6.43. Novartis reported sales of 13,620.00, net income of 3,606.00, and EPS of 2.28 for the latest quarter., net income of 3,606.00, and EPS of 2.28 for the latest quarter.

What was Novartis's net income for the latest quarter?

Novartis's net income for the latest quarter was 3,606.00.

How did Novartis's performance compare year-over-year in the latest quarter?

The company's revenue moved from 13,558.00 in the previous quarter to 13,620.00 in the latest quarter, and net income moved from 2,818.00 to 3,606.00 compared to the previous quarter.

What is Novartis's net profit margin on a TTM basis?

Novartis's trailing twelve months (TTM) net profit margin is 23.09%.

How does Novartis's debt to equity ratio compare to industry standards?

Novartis's total debt-to-equity ratio is 81.32%.

What is Novartis's return on investment on a TTM basis?

Novartis's trailing twelve months (TTM) return on investment (ROI) is 32.89%.

Did Novartis gain or lose cash last quarter?

In the latest quarter, Novartis's net change in cash was -4,393.00 million.

What were Novartis's total assets and liabilities in the latest quarter?

As of the latest quarter, Novartis reported total assets of 99,941.00 million and total liabilities of 31,619.00 million.

How has Novartis's total revenue grown this year?

Novartis's total revenue was 13,558.00 in the previous quarter and 13,620.00 in the latest quarter.

What is Novartis's gross margin on a TTM basis?

Novartis's trailing twelve months (TTM) gross margin is 75.68%.

What was Novartis's revenue per share for the latest quarter?

Novartis's revenue per share for the latest quarter was 49.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.